Searchable abstracts of presentations at key conferences in endocrinology

ea0036P69 | (1) | BSPED2014

Bone mass and body composition in adolescents with childhood onset GH deficiency

Ahmid M , Shepherd S , Perry C G , Mason A , Ahmed S F , Shaikh M G

Background: Childhood-onset GH deficiency (CO-GHD) is perceived to be a cause of low bone density and osteoporosis in adulthood. Data on bone mass and body composition of GH-treated adolescents with CO-GHD at final height are inconsistent.Aims: To compare size/height corrected parameters of bone mass and body composition in adolescents with CO-GHD at final height.Method: Review of CO-GHD treated patients at final height between 200...

ea0033oc1.3 | Oral Communications 1 | BSPED2013

The utility of AMH for predicting testosterone response to HCG stimulation in children with suspected DSD

Kyriakou Andreas , McNeilly Jane D , Shaikh M Guftar , Giacomozzi Claudio , Shapiro David , Ahmed S Faisal

Introduction: In children undergoing investigation of testicular function the relationship between serum anti-Müllerian hormone (AMH) and the testosterone response to hCG stimulation test (HST) is unclear.Methods: 71 children (three females and 68 males) with a median age of 1.08 years (range: 0.003, 14.3) were investigated for suspected DSD by AMH on D1 and testosterone on D1 and D4, before and after 3-day HST. Of these children, 27 had an addition...

ea0033p1 | (1) | BSPED2013

Plasma cortisol levels and adrenal weight in cases of death in childhood

Morrison R. , Khan J , Galloway P , McNeilly J , Penman D , Ahmed S F

Introduction: The incidence of adrenal insufficiency in cases of unexplained death in young children is unclear. It is also unclear whether there is a relationship between adrenal size and plasma cortisol concentration.Methods: All post-mortem (PM) reports of sudden deaths in children in the West of Scotland between 2010 and 2012 were retrospectively analysed. Combined adrenal weight (g) was recorded and expressed as the percentage of total body weight (...

ea0030p54 | (1) | BSPED2012

Management of childhood-onset GH deficiency in young adulthood

Ahmid Mahjouba , Perry C G , Donaldson M , Ahmed S F , Shaikh M G

Background: GH therapy in adolescents with childhood onset GH deficiency (CO-GHD) is often necessary to prevent adult GHD syndrome and requires a re-evaluation of the GH axis on attainment of final height. Not all individuals with CO-GHD remain GH deficient and re-evaluation is required to confirm or refute adult GHD.Aim: Review the care received by young adults diagnosed with CO-GHD.Design: Retrospective review of young adults wit...

ea0029oc3.5 | Diabetes Clinical | ICEECE2012

Study of toll like receptor 2 and 4 expression in monocytes in type 1 diabetes mellitus with and without micro-vascular complications

Sedek S. , Ahmed W. , Shelbaya S. , Baki R Abd El , Abass M.

Background: Toll-like receptors (TLRS) are a class of proteins that play a key role in the innate immune system. They are single, membrane, non catalytic receptors which are expressed in multiple tissues predominantely cells of the innate immune system especially monocytes. So, they play a critical role in the regulation of immune function and inflammation.Aim of our work: To study the expression of toll-like receptor 2 and 4 on monocytes in T1DM patient...

ea0028p110 | Clinical practice/governance and case reports | SFEBES2012

Audit of the West of Scotland endocrine adolescent transition clinic model, RHSC Glasgow, 2008–2010

Mason Avril , Donaldson Malcolm , Ahmed S. , McNeil Ethel , Campbell Victoria , Perry Colin , Shaikh M.

Introduction: Various models of transition are used to help engage and improve the health of young adults. Our transition clinic model: a multi-disciplinary endocrine Adolescent Transition Clinic (ATC), was instituted at the Royal Hospital for Sick Children, Glasgow, in October 2008 serving young people in the West of Scotland. A good transition process should improve clinic attendance, health outcomes and quality of life into adulthood.Aim: To review th...

ea0026p563 | Cardiovascular endocrinology and lipid metabolism | ECE2011

Determinants and outcome of amiodarone-associated thyroid dysfunction

Ahmed S , Van Gelder I C , Wiesfeld A C P , Van Veldhuisen D J , Links T P

Background: Amiodarone is frequently associated with thyroid dysfunction. Identifying predictors for amiodarone-associated thyroid dysfunction and assessing treatment outcome may aid clinicians in daily practice.Patients and methods: In our retrospective study, we included 303 consecutive patients with amiodarone therapy for cardiac arrhythmias (260 with atrial fibrillation and 43 with ventricular arrhythmias). Thyroid function tests were performed every...

ea0024p23 | (1) | BSPED2010

The impact of inflammatory bowel disease on pubertal growth is most marked in boys with Crohn’s disease

Mason A , Malik S , Russell R K , Bishop J , McGrogan P , Ahmed S F

Background: Puberty is understood to be commonly effected in adolescents with Crohn’s Disease (CD) and ulcerative colitis (UC). However, the extent of this effect and related problems with growth, have rarely been quantified.Objective: To determine the impact of CD and UC on pubertal growth.Methods: Retrospective study of 148 children with IBD (casenotes available, 135) who fulfilled the criteria for describing growth spurt pa...

ea0023p8 | (1) | BSPED2009

The Current UK Experience of Recombinant IGF1 For Cases of Severe Primary IGF1 Deficiency

Mushtaq Talat , Ahmed S Faisal , Emohare Osa , Patel Leena , Rose Stephen , Shaw Nick

Background: Severe primary IGF1 deficiency (SPIGFD) is defined in children as a height less than −3sds, low IGF1 levels with normal growth hormone levels. Recombinant IGF1 (rhIGF1, Mecasermin) given twice daily as a subcutaneous injection is the only therapy available to improve the height potential in this group of children. However it may have important side effects including hypoglycaemia, growth of lymphoid tissue and injection site lipohypertrophy.<p class="abst...

ea0019p290 | Reproduction | SFEBES2009

Serum anti-Mullerian hormone and The HCG stimulation test for investigating boys with disorders of sex development

Keir L , Ahmed S , McNeilly J , Galloway P , O'Toole S , Wallace A

Background: In XY disorders of sex development, a single measurement of serum Anti-Mullerian hormone (AMH) may replace the hCG stimulation test.Aim: To assess the level of concordance between serum AMH and hCG stimulated testosterone concentrations.Methods: About 284 children (M:F,154:130) with a median age of 8 years (10th, 90th centiles, 0.25,14) were used to establish a normal reference range for AMH. Clinical data were reviewed...